AFYA VP Junior Lelio de Souza Sells $623K of Stock
Afya Limited's Vice President sold over 41,500 shares, totaling $623,115.
Reviewed by automated data checks against the source filing. How we make and check alerts
Junior Lelio de Souza, Vice President at Afya Limited ($AFYA), sold 41,541 shares at an average price of $15, worth about $623,115, on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $AFYA is up 0.0% after 1 week, down 4.5% after 1 month and down 2.3% to date (from the $14.87 close on Jun 26, 2026).
AFYA
Afya Limited
Key Points
- Junior Lelio de Souza, Afya Limited's Vice President, sold 41,541 shares on June 26, 2026, for $623,115.
- Afya Limited, trading at $14.87 on Wednesday, has a market cap of about $1.36 billion and a P/E ratio of 9.29.
- Analysts have set a mean price target of $16.55 for Afya, with recent downgrades from B of A Securities and Morgan Stanley.
Get $AFYA trade alerts by text
We text you when insiders, Congress or big funds trade $AFYA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Afya Limited alert may contain errors. Disclosures
Junior Lelio de Souza, a Vice President at Afya Limited, sold 41,541 shares of the company on June 26, 2026. The shares were sold at an average price of $15.00 each, totaling approximately $623,115. This transaction was not part of a pre-planned stock sale program.
Insider Buying and Selling at Afya Limited
Junior Lelio de Souza's recent sale is one of several insider transactions at Afya Limited. On the same day, Vice President Basolli Gomiero Mirella sold 10,000 shares at $14.80 each. Earlier, on May 7, 2026, CEO Virgilio Deloy Capobianco Gibbon purchased 59,000 shares, while Vice President Coelho Ribeiro Erico sold 10,200 shares.
Afya Limited Stock Up 9.1%
Shares of NasdaqGS:AFYA traded near $14.87 on Wednesday. Afya Limited, a Brazilian medical education group, boasts a market cap of approximately $1.36 billion. The stock has a P/E ratio of 9.29 and a beta of 0.365, indicating relatively low volatility. Its 52-week range spans from $13.00 to $18.16, with a 50-day moving average of $14.35 and a 200-day moving average of $14.67.
Analysts Set New Price Targets
On June 22, 2026, JP Morgan maintained a 'hold' rating for Afya Limited with a price target of $21.00. Earlier in the year, B of A Securities downgraded the stock to 'hold' with a $17.00 target, while Morgan Stanley set a 'sell' rating with a $16.00 target. The consensus among analysts is an 'underperform' rating, with a mean target price of $16.55.
About Afya Limited
Afya Limited, headquartered in Belo Horizonte, Brazil, operates as a medical education group. It offers undergraduate and continuing education programs, and medical practice solutions. The company is led by CEO Virgilio Deloy Capobianco Gibbon and employs nearly 9,400 people. Afya's educational services span various health and non-health fields, and it provides digital tools for medical professionals.
Bottom Line
Junior Lelio de Souza's recent sale of Afya Limited shares is one of several insider transactions this year. Investors closely watch such moves for potential signals about a company's prospects. While insider sales can raise questions, they are not uncommon and may not reflect the company's current standing. As always, it's important to consider the broader market context and individual investment goals.
Related Filing Alerts
Source: Junior Lelio de Souza's Form 4 filing on $AFYA (Jun 26, 2026). Find the original filing: AFYA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts